D
URING experiments conducted to determine changes in cardiac murmurs produced by elevating systemic arterial blood pressure, we noted as had others, 1 ' 2 that patients demonstrated varying responses in heart rate during levarterenol-induced hypertension. Pinnerty, Tuckman, and Hajjar 2 coneluded that a decreased bradycrotic response during levarterenol infusion was due to sclerosis of the thoracic aorta and its immediate branches.
Our purpose is to present our data suggesting that cardiac disease itself, in the absence of atherosclerosis of the aorta, may provoke a decreased bradycrotic response during levarterenol infusion.
Methods Thirty-four persons with heart disease were studied. Only 1 (C.P.) had congestive heart failure at the time of study. Six had congenital, 5 coronary, 1 hypertensive and 23 rheumatic heart disease. Fifteen were males; 19 females. Their ages varied from 20 to 72 years.
All patients were supine throughout the experiment. Levarterenol-bitartrate (Levophed) was administered as an intravenous infusion in a concentration of 4 /ig./ml. of 5 per cent dextrose in water. The infusion was given as a slow drip until the blood pressure had risen just in excess of 20 per cent of its preinfusion level. The infusion was slowed or discontinued if chest pain, dyspnea or headache occurred. The arterial blood pressure was recorded by the usual auseultatory method. The mean arterial pressure was determined by the formula systolic plus diastolic divided by 2. The blood pressure was determined repeatedly while the electrocardiogram, the heart sounds and, at times, a ballistocardiogram were being monitored on an oscilloscope and recorded From tlic Division of Cardiology, Temple University School of Medicine and Hospital, Philadelphia, Pa.
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Results The heart rate slowed in 24 patients (table  1) , did not change in 4 (table 2) , and increased in 6 (table 3) . The average rise in mean and systolic arterial pressures after administration of levarterenol in the first group were 30 and 34.1 per cent respectively, 21 and 20 per cent in the second, and in the third, 27 and 43.2 per cent, excluding one (J.L.), whose mean pressure could not be calculated because, although the systolic one was the highest of all, the diastolic sound could be heard at zero pressure.
The average fall in heart rate of the first group was 13.8 beats/min., but it varied from 1 to 39. Eight had falls of 6 or less beats/min. Of these 8, 3 had rheumatic heart disease, 1 congenital, 1 mild benign hypertension and 3 coronary artery disease. In 2 of the last 3 (S. J. and J. von Z.), atherosclerosis of the aorta was suspected on clinical grounds.
Half of those whose heart rate slowed and half of those whose heart rate did not change had been digitalized and were on a maintenance dose of digitalis. Five of the 6 whose heart rate quickened had been digitalized and were on a maintenance dose of digitalis. The remaining 1 had shortness of breath on effort and recurrent arrhythmias which had not responded to previous digitalization and, for that reason, digitalis had been discontinued several weeks previously.
Of those whose heart rate slowed, 7 were in the third decade, 6 in the fourth, 7 in the fifth, 2 in the sixth, 1 in the seventh and the last in the eighth. Of those whose heart rate did not change, 1 was in the third, 1 in the fourth, 1 in the fifth and 1 in the sixth decades. Of those whose heart rate quickened, 2 were in the fourth, 2 in the fifth, 1 in the sixth and 1 in the seventh decades. The heart rate slowed in all with congenital, 13 with rheumatic, 1 with hypertension and 4 with coronary artery disease. Four with rheumatic heart disease had little change in heart rate. Five with rheumatic heart disease and the remaining 1 with coronary artery disease, developed a faster rate; one (F.K.) subsequently died in congestive heart failure. Discussion Our studies were primarily concerned with changes in the characteristics of cardiac murmurs produced by elevating systemic arterial blood pressure. For this reason, our population was primarily of rheumatic origin. Patients with hypertension or coronary artery disease were studied only if murmurs of uncertain origin were present. There was nothing in the physical, roentgenographic or electrocardiographic examination suggesting significant atherosclerosis of the aorta. There was, particularly, nothing suggestive of thoracic aortic atherosclerosis, or its branches, in the group in which heart rates quickened or did not change, or in the 8 whose heart rates slowed 6 or less beats/min. after the infusion of levarterenol. Only 4 of these 18 had evidence of coronary atherosclerosis. The presence or absence of digitalization likewise did not separate the groups.
On the other hand, that specific valvular lesions were not the cause of difference in response of the heart rate is indicated by the presence of similar valvular lesions in all 3 groups.
Our data are in agreement with others 1 " 3 that the per cent increase in mean and systolic arterial blood pressure is not the determining factor which governs the response of the heart rate. We also found, as did Finnerty, 2 that manual massage of the carotid sinus can slow the heart rate in those whose heart rate did not slow after an intravenous infusion of levarterenol. It is well known 4 that patients with cardiovascular disease, elderly persons, and those digitalized, developed more frequent and more marked findings after manual compression of the carotid sinus. We also can confirm Finnerty's observation that the injection of atropine can quicken the heart beat, regardless of its response to levarterenol. These observations indicate that the carotid sinus and its efferent arc are active in all 3 groups. It has also been shown that the carotid sinus reflex, at least in the healthy dog, is sensitive enough to respond to as little a change as 1 mm. Hg of systemic arterial blood pressure. 5 We were able to correlate the response of the heart rate to levarterenol only with our clinical estimation of the degree of cardiac disability. Five of the 6 whose heart rates quickened could not remain compensated without digitalis. The sixth had repeated attacks of cardiac arrhythmias and dyspnea which had not been relieved by previous digitalization. Of the 4 whose heart rates did not change, 2 could not do without digitalis. The third (J.D.) had unusually severe aortic stenosis requiring open-heart surgery for relief. The fourth had severe mitral regurgitation. Seven of the 8 whose heart rate slowed 6 or less beats /min. had marked intolerance to effort. One of these (C.P.) was in chronic congestive failure and required open-heart surgery for relief. The only one without significant symptoms was II.C, who had an intra-atrial septal deCirculation Research. Volume VIII, March 1960 feet. All but 2 whose heart rate slowed had relatively minor symptoms. One with marked effort limitation and an interventricular septal defect had a slower heart rate because of the development of bigeminus. The other had tight mitral stenosis requiring surgery for relief. Although her heart rate slowed, a tachycardia of 115/min. persisted during the infusion of levarterenol.
Of the 3 patients who were operated upon, C.P. died after open-heart surgery. Autopsy revealed a normal aorta, free of atherosclerosis. The other 2 patients were restudied to determine if a change in cardiac performanceproduced by surgery could change the reaction to an intravenous infusion of levarterenol. After surgery, L.P. improved, as was confirmed by cardiac catheterization 6 months later. Pulmonary artery and right ventricular pressures were lower while the cardiac output remained unchanged. Her heart rate had dropped to 84/min., and during levarterenol sufficient to raise systolic pressures, 25 mm. Hg to 58/min. J.D. was not recatheterized because of persistent incisural drainage following a mediastinal infection after openheart surgery. He appears improved from the clinical standpoint. Levarterenol sufficient to raise the systolic pressure 40 mm. Hg dropped the heart rate from 78 and 48/min.
Levarterenol has a complex action on the cardiovascular system. It tends to increase cardiac work by increasing aortic resistance. It tends to slow the heart by stimulating the carotid sinus baroreceptors. Stroke work must be considerably increased to maintain the car- diac output. If the diseased heart cannot increase adequately, its stroke work, compensatory mechanisms, 1 of which is tachycardia, may be invoked. The interplay of cardiac reserve and carotid sinus stimulation may determine the cardiac rate during levarterenol infusion.
Such a mechanism could also explain Finnerty's results. All of his patients in group 4 had enlarged hearts and 9 of 11 in group 3 had enlarged hearts, myocardial infarction, conduction defects, or a combination of these faults.
It would therefore appear to us unsound to regard a decreased bradycrotic response to infusion of levarterenol as due to atherosclerosis of the aorta and its branches in a person with cardiac disease which significantly encroaches upon or has surpassed the heart's reserve.
Summary
Levarterenol-induced hypertension may slow, increase or produce no change in the cardiac rate of persons with cardiovascular disease. The degree of cardiac disability at least partly determines the type of response.
Summario in Interlingua
In personas con morbo cardiovascular, hypertension intlucito per levarterenol pote reducer, augmentar, o non influential-del toto le frequentia cardiac. Le gnido de invaliditate cardiac determina al minus in parte le typo de responsa obteuite.
